Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...

The second healthcare sector IPCEI – approving up to €403 million of State aid by five Member States, including France, ...

Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the ...

Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

As usual, the one-two punch of ASCO and BIO set us a bit behind, but never fear – your June hires round-up is here at least ...

In a post-ASCO 2025 conversation, pharmaphorum web editor Nicole Raleigh spoke with Dr Pamela Tenaerts, chief medical officer at Medable, about the company’s new digital-first model to handle ...

Nevertheless, there are issues here, too, with long waiting lists, resource constraints, and patient strife when attempting ...

SCOPE is testing administration of intramuscular SCIB1 and intradermal iSCIB1+, which codes for various melanoma antigens ...

The FDA appears to have won its staring contest with Sarepta over shipments of Elevidys, after the company blinked and agreed ...

Healthcare services are critical for prevention, but they do not have the capacity to drive a prevention healthcare ...

Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was ...

The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category.